Rheumatology
Overview
Rheumatology is a peer-reviewed medical journal that focuses on the study and treatment of rheumatic diseases. It publishes high-quality research articles, clinical studies, and reviews, covering topics such as arthritis, connective tissue disorders, musculoskeletal conditions, and autoimmune diseases. The journal serves as a valuable resource for rheumatologists, researchers, and healthcare professionals seeking to advance knowledge and improve patient care in the field of rheumatology.
Details
Details
Abbr.
Rheumatology (Oxford)
Publisher
Oxford University Press
Start
1999
End
Continuing
Frequency
Monthly
p-ISSN
1462-0324
e-ISSN
1462-0332
Country
United Kingdom
Language
English
Specialty
Rheumatology
Metrics
Metrics
h-index / Ranks: 739
198
SJR / Ranks: 1538
1721
CiteScore / Ranks: 1874
8.80
JIF / Ranks: 1321
5.5
Recent Articles
1.
Colitta A, Bruno S, Bazzani A, Cruz-Sanabria F, Frumento P, dAscanio P, et al.
Rheumatology (Oxford)
. 2025 Mar;
PMID: 40088934
Objective: Sleep disturbances significantly impact Behçet's Syndrome (BS) patients' quality of life. Defining the correlates of BS patients' sleep disturbances is needed to improve their management and, in turn, BS...
2.
Chung L, Silver R, Steen V, Furst D, Castelino F, Trojanowski M, et al.
Rheumatology (Oxford)
. 2025 Mar;
PMID: 40088930
Objectives: To determine the efficacy, safety, and pharmacodynamics of belumosudil in patients with diffuse cutaneous systemic sclerosis (dcSSc) treated with background immunosuppressive therapies. Methods: Eligible patients were randomised 1:1:1 to...
3.
Menentoglu B, Konur Akbas E, Kavrul Kayaalp G, Akgun O, Aslanger A, Uyguner Z, et al.
Rheumatology (Oxford)
. 2025 Mar;
PMID: 40085019
No abstract available.
4.
Grosso G, Giannopoulou N, Tsoi A, Cetrez N, Nikolopoulos D, Lindblom J, et al.
Rheumatology (Oxford)
. 2025 Mar;
PMID: 40085009
Objective: To determine the efficacy of belimumab on mucocutaneous manifestations of systemic lupus erythematosus (SLE) in a large integrative analysis. Methods: Using data from five phase III clinical trials (BLISS-52;...
5.
Naddaf E, Skolka M, Prokop L, Dimachkie M, Hogrel J, Benveniste O, et al.
Rheumatology (Oxford)
. 2025 Mar;
PMID: 40085004
Objectives: Inclusion body myositis (IBM) is characterized by slowly progressive muscle weakness making it challenging to detect weakness changes during a clinical trial. Trial participants receiving placebo may behave differently...
6.
Xu S, Jiemy W, van Sleen Y, Westra J, Graver J, van der Geest K, et al.
Rheumatology (Oxford)
. 2025 Mar;
PMID: 40084998
Objective: Giant cell arteritis (GCA) is a systemic vasculitis of large- and medium-sized arteries characterized by granulomatous inflammation and vascular remodelling. Although fibroblasts are the predominant cell type in the...
7.
Pathak A, Kelleher E, Brennan I, Amarnani R, Wall A, Murphy R, et al.
Rheumatology (Oxford)
. 2025 Mar;
PMID: 40084994
Objectives: Sleep disturbance is a key symptom of fibromyalgia and a risk factor for chronic widespread pain. This systematic review and meta-analysis aims to assess the effectiveness of pharmacological treatments...
8.
Dinsdale G, Murray A, Manning J, Dickinson M, Herrick A, Taylor C
Rheumatology (Oxford)
. 2025 Mar;
PMID: 40073248
Objectives: Our overall aim was to develop a smartphone app to collect photographic images of Raynaud's phenomenon (RP) attacks alongside patient reported outcome measures (PROMs). Specific objectives included assessing the...
9.
Peverelli M, Tarkin J
Rheumatology (Oxford)
. 2025 Mar;
64(Supplement_1):i33-i37.
PMID: 40071433
Imaging plays an important role in the clinical management of patients with large-vessel vasculitis (LVV), both to confirm the diagnosis at the time of initial presentation and to identify disease...
10.
Egan A, Khoury P
Rheumatology (Oxford)
. 2025 Mar;
64(Supplement_1):i19-i23.
PMID: 40071432
Eosinophil basic biology, including immunoregulatory functions, plays a complex role in a myriad of disorders where eosinophils play a role. Established in vivo and in vitro models and novel emerging...